1479 / 1544
Final Remarks
SBRT is currently widely accepted as the best alternative to
surgery for early stage lung cancer
SBRT is feasible with various technical solutions,
apparently without any difference in outcomes
Mature data on long-term follow up are needed to better
understand the pattern of relapse
Predictive and prognostic factors are needed to better
select patients at higher risk of progression for possible
adjuvant therapies
03/01/13